About Coiled-coil domain-containing protein 112
Coiled-coil domain-containing protein 112 (CCDC112) is a protein
from Homo sapiens identified by UniProt accession
Q8NEF3, 446 residues long.
MolForge cross-references it against 0 known binders and
14 disease associations.
Target properties
| Protein name | Coiled-coil domain-containing protein 112 |
| UniProt accession | Q8NEF3 |
| Gene | CCDC112 |
| Organism | Homo sapiens |
| Length | 446 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (14)
Diseases linked to this target (Open Targets).
- cardioembolic stroke · score 0.06
- gestational diabetes · score 0.05
- chronic obstructive pulmonary disease · score 0.04
- cardiac arrhythmia · score 0.04
- protein measurement · score 0.02
- neoplasm · score 0.02
- hepatocellular carcinoma · score 0.01
- Myopia · score 0.01
- myopia · score 0.01
- Astigmatism · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NEF3-F1 | alphafold | PREDICTED | 81.65 | — |
Amino-acid sequence (446 residues)
MEKDKHSHFY NQKSDFRIEH SMLEELENKL IHSRKTERAK IQQQLAKIHN NVKKLQHQLK DVKPTPDFVE KLREMMEEIE NAINTFKEEQ RLIYEELIKE EKTTNNELSA ISRKIDTWAL GNSETEKAFR AISSKVPVDK VTPSTLPEEV LDFEKFLQQT GGRQGAWDDY DHQNFVKVRN KHKGKPTFME EVLEHLPGKT QDEVQQHEKW YQKFLALEER KKESIQIWKT KKQQKREEIF KLKEKADNTP VLFHNKQEDN QKQKEEQRKK QKLAVEAWKK QKSIEMSMKC ASQLKEEEEK EKKHQKERQR QFKLKLLLES YTQQKKEQEE FLRLEKEIRE KAEKAEKRKN AADEISRFQE RDLHKLELKI LDRQAKEDEK SQKQRRLAKL KEKVENNVSR DPSRLYKPTK GWEERTKKIG PTGSGPLLHI PHRAIPTWRQ GIQRRV
Explore Coiled-coil domain-containing protein 112 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets